Study demonstrates efficacy of new treatment for neurofibromatosis type 1-related tumors
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP)
Read more
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP)
Read moreIn a new study, researchers at Karolinska Institutet in Sweden have used a urine test to identify and verify a
Read more(HealthDay)—On average, glycemic control improved during lockdown among people living with type 1 diabetes, according to a study published online
Read moreTUESDAY, Dec. 1, 2020 — Patients presenting with chilblain-like lesions during the COVID-19 pandemic have histologic and biologic patterns of
Read moreThe investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients
Read moreTwo newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly
Read moreResults of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients
Read moreDiabetic retinopathy is one of the main vascular complications of type 2 diabetes, and the most common cause of visual
Read moreInvestigators at St. Jude Children’s Research Hospital, the European Molecular Biology Laboratory, and the German Cancer Research Center have identified
Read moreA multi-center team of researchers led by Children’s Hospital of Philadelphia (CHOP) has discovered a genetic signature that could help
Read more